Authors


Maria Roberts, PharmD

Latest:

Social Determinants of Health Matter When Treating Patients With Breast Cancer

Pharmacists play a critical role in treating patients with breast cancer and can help address their social determinant of health challenges.


Carolyn J. Graziano, DPT, MBA

Latest:

Rising Use of Herbal Supplements Creates Awareness of Risks During the Perioperative Period

Pharmacists can get involved by counseling patients on when to halt use of supplements, as well as proper use and selection of products.


Marlene Wang, MS

Latest:

Clinical Overview: Tildrakizumab-asmn (Ilumya) for Plaque Psoriasis

Tildrakizumab-asmn is a humanized IgG1/k monoclonal anti-IL-23 antibody indicated for the treatment of adults with moderate-to-severe plaque psoriasis.


Daniel Ryabo, PharmD candidate 2025; Ifra Khan, PharmD candidate 2025; Aslan Amirov, PharmD candidate 2025; Mahmoud Shahin, PharmD candidate 2025; Tina Zerilli, PharmD

Latest:

Clinical Overview: Lecanemab Offers Hope for Patients With Alzheimer Disease

Lecanemab is a humanized immunoglobulin gamma 1 monoclonal antibody that targets amyloid plaques, which are thought to play a role in the development and progression of Alzheimer disease.


Arman Melikyan, PharmD Candidate

Latest:

Introducing Obecabtagene Autoleucel: A New Chapter in ALL Treatment

Obecabtagene autoleucel improves CAR T-cell therapy for B-cell ALL.


Sara Panella, PharmD, BCPS

Latest:

Transitions of Care in Patients With Recurrent C. Diff: An Opportunity for Collaboration Among Community, Health System Pharmacists

Approximately 450,000 cases of Clostridioides difficile infection occur each year in the United States and approximately 25% of patients treated for an initial episode will experience recurrence.


Sabiyah Siddiqui

Latest:

Deprescribing Helps Optimize Medication Use

Frequent reassessments of therapy regimens address polypharmacy, particularly for older patients.


Carrie Koenigsfeld, PharmD, FAPhA

Latest:

Future Management Considerations of RSV

Panelists discuss the evolving management of RSV, highlighting the importance of increasing awareness and education, anticipating advances in testing, data reporting, and treatment options like monoclonal antibodies and antivirals, and considering future vaccination strategies such as booster doses to enhance prevention and patient outcomes.



Christopher Burke

Latest:

Building Resilience: Opportunities for US Pharma to Strengthen Public Health in Africa Amid Changing Aid Policies

Africa’s rapidly growing population, expected to reach 2.5 billion by 2050, means an increasing demand for health care and medications.


Michael D. Brown

Latest:

Addressing Ongoing Hospital Pharmacy Staffing Challenges

At a time when pharmacist burnout and turnover is higher than ever before, talent retention is increasingly a strategic imperative for hospitals.


Kaitlyn W. Miller, PharmD, BCOP

Latest:

Clinical Outcomes of Oral Anticancer Regimens in NSCLC Patients Managed in an Integrated Health-System Specialty Pharmacy Program

Pharmacist interactions provide significant benefits for patients with non-small cell lung cancer treated with oral oncolytics.


Nicola Harte, MSc

Latest:

Healing Trust in Medicine in a Fractured Post-Pandemic Landscape

The pandemic’s aftermath left lasting tensions in health care.


Betsy Impreso, CPhT

Latest:

Pharmacy Technicians as Non-Pharmacist Preceptors for a Sterile Compounding Rotation

Recognizing pharmacy technicians as non-pharmacist preceptors can provide an opportunity for professional development while encouraging technicians to practice at the top of their education and training activities.


John Vinson, PharmD

Latest:

Walgreens Doubles Down on Care Team Integration

But the role of the pharmacy chain in health systems, primary care, and specialty is uncertain.


Fenil Patel, NSU College of Pharmacy '23

Latest:

The Benefit of Integrating Residency Workshops Into Pharmacy School Curriculum

In light of the growing numbers of students opting for post-graduate trainings, colleges and schools of pharmacy may want to consider offering electives geared toward exposing students to post-graduate career possibilities and provide guidance toward success.


Jessica Paulus, ScD Epidemiology

Latest:

ASCO 2025: Racial Disparities and Advanced Staging in Early-Onset Colorectal Cancer

A study of early-onset colorectal cancer found significant racial disparities, with younger patients more frequently diagnosed at advanced stages.


Rachel Gilmore, PharmD

Latest:

Removing Mesna From Cyclophosphamide Cycles in VAdriaC-IE for Ewing Sarcoma

This retrospective cohort study provides preliminary evidence for safe removal of mesna from VAdriaC cycles, as the incidence of hemorrhagic cystitis did not increase in patients with Ewing sarcoma who received cyclophosphamide without prophylactic mesna.


Jennifer Splawski and Ramsey Doany

Latest:

RFID is the Future of Hospital Efficiency: Here’s Why You Should Get Involved

Radio frequency identification-enabled automation for inventory management has only achieved its massive adoption in the retail space over the past 2 decades.


Brijesh Gautama, MPharm (Hons), MSc, PGDip

Latest:

Management of Cytopenia Post CAR T-Cell Therapy

This review explores cytopenia after CAR T-cell therapy, including its risk stratification and management with growth factors, thrombopoietin-receptor agonists, and hematopoietic stem cell boosts.


Geena Eglin, PharmD, BCACP, CSP, CPP

Latest:

Potential Safety Concerns With Evinacumab

This case report depicts a probable infusion reaction in a 61-year-old woman prescribed evinacumab for the treatment of familial hypercholesterolemia.



Courtney Cavalieri, PharmD, BCOP

Latest:

Discussing the Role of the Pharmacist in the Management of Biliary Tract Cancer

Panelists discuss how pharmacists play a crucial role in biliary tract cancer management by leveraging their detailed medication knowledge to assist with treatment selection, develop comprehensive monitoring plans (especially for hyperphosphatemia with FGFR inhibitors and cardiac monitoring with HER2 therapies), educate patients about unique toxicities and self-management strategies, create clinic workflow algorithms for toxicity management, and advocate for maximizing time on therapy as long as patients maintain response or stable disease given the limited treatment options available for this rare cancer type.


Katharine Russo, PharmD

Latest:

Pharmacists Are Over-Looked Travel Specialists

As the summer months approach, pharmacists can offer many services to ensure patients remain safe and healthy during their travels.


Brian Gaul, PharmD, RPh

Latest:

Drafts, Laughs, and Lasting Lessons: Inside a Unique Medical Writing Experience

The University of Connecticut's Medical Writing Certificate program transforms aspiring writers into confident communicators through hands-on training and real-world experience.


Donald Alcendor, PhD

Latest:

COVID-19 Booster Shots and the Future

Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.


Elise Capson

Latest:

Pharmacy Students Lead Drive-Through Influenza Vaccination Event

Idaho State University partners with the Idaho Immunization Coalition to effectively and safely vaccinate patients against influenza.


Sirj Goswami, PhD

Latest:

How Precision Dosing Technology Helps Prevent Adverse Events

Precision dosing technology uses multiple patient-specific factors to individualize medication doses, helping clinicians reduce medication errors that lead to adverse events.


Mary Sullivan Kirkland, PharmD candidate

Latest:

Phage Therapy: Exploring the Future of Infection Treatment

Phage therapy, which uses lytic bacteriophages to target antibiotic-resistant bacteria, has resurfaced as a promising treatment for multidrug-resistant infections, but faces challenges in regulation, production, and clinical implementation despite its growing evidence of efficacy.


Rachel K. Anderson, PharmD, CSP

Latest:

Numerous Clinical Trials Investigate Next Generation of PARP Inhibitors

Therapy effectively treats cells harboring HR deficiencies, including those of specific types of ovarian, breast cancers.